<DOC>
	<DOCNO>NCT01357135</DOCNO>
	<brief_summary>This observational study compare effectiveness dual therapy Type II diabetes mellitus metformin + sitagliptin versus metformin + sulfonylurea routine clinical practice France .</brief_summary>
	<brief_title>An Observational Study Type II Diabetics Treated With Dual Therapy With Without Sitagliptin ( Januvia速/Xelevia速 , MK-0431-201 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Type 2 diabetes participant De novo treatment ( first prescription date within past 8 week ) : Metformin + sitagliptin dual therapy , Metformin + sulfonylurea dual therapy , Sitagliptin part another treatment regimen Participants also eligible treatment sitagliptin ( Januvia速/Xelevia速 ) sulfonylurea .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>